The Vanguard Group 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:55 pm Sale | 2026-03-13 | 13G | VAXCYTE INC PCVX | The Vanguard Group | 0 0.000% | -8,452,371 (Position Closed) | Filing |
| 2024-02-13 5:16 pm Purchase | 2023-12-29 | 13G | VAXCYTE INC PCVX | The Vanguard Group | 8,452,371 8.880% | 1,838,705 (+27.80%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | VAXCYTE INC PCVX | The Vanguard Group | 6,613,666 8.370% | 3,479,380 (+111.01%) | Filing |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | VAXCYTE INC PCVX | The Vanguard Group | 3,134,286 5.940% | 3,134,286 (New Position) | Filing |